Limb-sparing treatment for canine osteosarcoma to be explored in new studyNovember 14, 2023The new research is set to evaluate the effectiveness of a novel drug combination tailored to giant-breed dogs diagnosed with osteosarcoma.
SPONSORED CONTENTProtect your patients from the start.Simparica Trio (sarolaner, moxidectin, and pyrantel chewable tablets) is the first monthly preventative of its kind. Combining three ingredients for month-long protection. + Learn more
VPN Plus+ ExclusiveIntroduction to Oncology: Easy Peasy BasicsMay 12, 2023This session: Lindsay Hallman, VTS, touches on the history of cancer, and chemotherapy, as well as the modern use of chemotherapy in veterinary medicine. The second half of the lecture focuses on common oncological emergencies, hemangiosarcoma, osteosarcoma, mast cell tumors, and lymphoma.
Limb-sparing options for osteosarcoma-diagnosed dogs to be exploredJuly 28, 2022The Morris Animal Foundation-funded project will investigate limb-sparing options for large- and giant-breed dogs diagnosed with osteosarcoma. Ultimately, researchers hope to advance the treatment of and improve the prognosis for dogs receiving radiation treatment for this type of cancer.
The future of canine cancer treatmentMarch 15, 2022The use of immunotherapies to treat cancers has become increasingly widespread in human medicine, with some of these promising therapeutics producing remarkable outcomes.
More on oral tumors in juvenile patientsJune 1, 2021Though PSCC can occur in dogs of any age, if a young dog is presented with a verrucous tumor of the rostral mandible or maxilla, it is often a PSCC.
Individualized care central to trial canine osteosarcoma treatment methodNovember 16, 2020Dogs diagnosed with a deadly form of bone cancer may soon have a greater chance of survival, thanks to the expansion of a clinical trial.
Stereotactic radiation may offer better outcomes in nine cancersOctober 24, 2019New data suggests a specific advanced radiation treatment protocol is leading to better survival outcomes than other therapy options for at least nine tumor types. That's according to PetCure Oncology, which presented its findings at the recent Veterinary Cancer Society Annual Conference (VCS) in Houston, Tex. The pet cancer care provider says nine of the 11 tumor types it studied showed increased median survival time relative to the current body of peer-reviewed published literature for pets treated with stereotactic radiation/stereotactic radiation therapy (SRS/SRT), an advanced form of radiation therapy used in human medicine. The list of tumor types includes brain, nasal, osteosarcoma (bone tumors), mast cell, and melanoma. "We have now treated more than 3,000 pets on-protocol with radiation therapy, including more than 2,200 with stereotactic radiation," says PetCure's chief medical officer, Neal Mauldin, DVM, DACVIM (internal medicine and oncology), DACVR (radiation oncology). "The good news is that many of them are still alive and thriving, so the data is still maturing. But objective analysis of the preliminary data at this point suggests stereotactic radiation can be considered a standard of care for the treatment of many tumor types, much like it already is in human cancer treatment. This …
Osteosarcoma in dogs and children genetically similarJuly 26, 2019The veterinary community might soon see advancements in the treatment of canine osteosarcoma (OS).
Osteosarcoma: Beyond amputation and euthanasiaMarch 12, 2019When a patient is diagnosed with osteosarcoma, we tend to focus on three options: • the "gold standard," i.e. amputation with or without chemotherapy; • what many call palliative care, meaning pain medication and rest; or • euthanasia. But what if amputation is not an option? What if chemotherapy or radiation is out of the owner's financial capabilities? Or a couple of medications are not enough to numb the pain? What if visible metastasis to the lungs is already present? Bob Stein, DVM, pain management guru and founder of the Veterinary Anesthesia & Analgesia Support Group (www.vasg.org), recently shared another valid option.* "With my suggested approach, we can often provide quality of life to even large-breed dogs for six to 12 months and sometimes more than 20." Let's detail Dr. Stein's protocol. Pamidronate Pamidronate, a bisphosphonate, is an injectable drug that is inexpensive and easy to administer (ref: TM Fan et al. JVIM 2007). It helps to reduce pain (in 30 to 50 percent of patients), inhibit bone osteolysis, and has potential cancer-suppression effects by impeding proliferation and inducing apoptosis. The drug has a wide safety margin and can even be used on patients with renal or …
